SCHEMBL23927240

SCHEMBL23927240

Cc1nc(Nc2ncc(C(=O)NC3=C[SH](Cl)C=C3C(F)F)s2)cc(N2CCN(C)CC2)n1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIK2 Q9H0K1 14/20 0.62
SIK3 Q9Y2K2 14/20 0.62
SIK1 P57059 12/20 0.62
ABL1 P00519 14/20 0.61
PKMYT1 Q99640 3/20 0.53
SRC P12931 5/20 0.53
BCR P11274 4/20 0.52
LCK P06239 3/20 0.52
HDAC1 Q13547 2/20 0.52
EPHB6 O15197 2/20 0.52
EGFR P00533 2/20 0.52
FYN P06241 2/20 0.52
CSF1R P07333 2/20 0.52
YES1 P07947 2/20 0.52
LYN P07948 2/20 0.52
RET P07949 2/20 0.52
HCK P08631 2/20 0.52
KIT P10721 2/20 0.52
BRAF P15056 2/20 0.52
EPHA1 P21709 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23927260 0.85 SIK2 (0.59) SIK2SIK3SIK1ABL1PKMYT1
SCHEMBL23927256 0.80 SIK2 (0.81) SIK2SIK3SIK1ABL1PKMYT1
SCHEMBL4257532 0.77 SIK2 (0.67) SIK2SIK3SIK1ABL1PKMYT1
SCHEMBL23987816 0.77 SIK2 (0.89) SIK2SIK3SIK1ABL1PKMYT1
SCHEMBL31307340 0.77 SIK2 (0.89) SIK2SIK3SIK1ABL1PKMYT1
SCHEMBL30151983 0.77 SIK2 (0.77) SIK2SIK3SIK1ABL1PKMYT1
SCHEMBL23927249 0.77 SIK2 (0.85) SIK2SIK3SIK1ABL1PKMYT1
SCHEMBL23927268 0.77 SIK2 (0.77) SIK2SIK3SIK1ABL1PKMYT1
SCHEMBL31688158 0.77 SIK2 (0.66) SIK2SIK3SIK1ABL1PKMYT1
SCHEMBL23987815 0.77 SIK2 (1.00) SIK2SIK3SIK1ABL1PKMYT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3901151-A1 HALOGENATED-HETEROARYL AND OTHER HETEROCYCLIC KINASE INHIBITORS, AND USES THEREOF iOmx Therapeutics AG (DE) 2021-10-27 EP disclosed